Skip to search formSkip to main contentSkip to account menu

T 3262

Known as: T-3262 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
The intracellular antimicrobial activity of tosulfoxacin was tested against Salmonella enteritidis C-32 by using human lung… 
1990
1990
The in vitro activity of tosufloxacin (A-61827; T-3262) against 15 clinical isolates of Chlamydia trachomatis and 31 recent… 
Highly Cited
1989
Highly Cited
1989
Tosufloxacin (A-61827) is the tosylate salt of A-60969 (T-3262). Temafloxacin (A-62254) is the hydrochloride salt of A-63004… 
1989
1989
The in vitro activity of a new fluoroquinolone, tosufloxacin (T-3262), against 111 pathogenic Nocardia strains was studied by an… 
1989
1989
T-3262 is a new antibacterial drug which has been developed for oral administration in clinical use. It is known that T-3262 has… 
1989
1989
For the purpose of evaluation of clinical efficacy, safety and usefulness on acute infectious enteritis (bacillary dysentery, and… 
1989
1989
Comparing with other pyridonecarboxylic acids (PCAs), the neurotoxicity of (+/-)-7-(3-amino-1-pyrrolidinyl)-6-fluoro-1-(2,4… 
1989
1989
For the purpose of evaluation of clinical efficacy, safety and usefulness on Salmonella enteritis, T-3262 (Tosufloxacin tosilate… 
1989
1989
JIRO SASAKI,*1 AKIHIRO KANEKO,*1 HIROSHI TAKAI,*2 KATSUYOSHI IKESHIMA,*2 KAZUO SHIIKI,*3 MASATAKA UEMATSU*3 TAKEFUMI MORIHANA,*4… 
1988
1988
The in vitro activities of three newly developed quinolone drugs (T-3262, NY-198, and fleroxacin [AM-833; RO 23-6240]) against 10…